TY - JOUR
T1 - KCNV2-associated retinopathy
T2 - genotype-phenotype correlations - KCNV2 study group report 3
AU - de Guimaraes, Thales A.C.
AU - Georgiou, Michalis
AU - Robson, Anthony G.
AU - Fujinami, Kaoru
AU - Vincent, Ajoy
AU - Nasser, Fadi
AU - Khateb, Samer
AU - Mahroo, Omar A.
AU - Pontikos, Nikolas
AU - Vargas, Maurício E.
AU - Thiadens, Alberta A.H.J.
AU - de Carvalho, Emanuel R.
AU - Nguyen, Xuan Than An
AU - Arno, Gavin
AU - Fujinami-Yokokawa, Yu
AU - Liu, Xiao
AU - Tsunoda, Kazushige
AU - Hayashi, Takaaki
AU - Jiménez-Rolando, Belén
AU - Martin-Merida, Maria Inmaculada
AU - Avila-Fernandez, Almudena
AU - Salas, Ester Carreño
AU - Garcia-Sandoval, Blanca
AU - Ayuso, Carmen
AU - Sharon, Dror
AU - Kohl, Susanne
AU - Huckfeldt, Rachel M.
AU - Banin, Eyal
AU - Pennesi, Mark E.
AU - Khan, Arif O.
AU - Wissinger, Bernd
AU - Webster, Andrew R.
AU - Heon, Elise
AU - Boon, Camiel J.F.
AU - Zrenner, Eberhard
AU - Michaelides, Michel
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
PY - 2024/8
Y1 - 2024/8
N2 - Background/aims To investigate genotype-phenotype associations in patients with KCNV2 retinopathy. Methods Review of clinical notes, best-corrected visual acuity (BCVA), molecular variants, electroretinography (ERG) and retinal imaging. Subjects were grouped according to the combination of KCNV2 variants-two loss-of-function (TLOF), two missense (TM) or one of each (MLOF)-and parameters were compared. Results Ninety-two patients were included. The mean age of onset (mean±SD) in TLOF (n=55), TM (n=23) and MLOF (n=14) groups was 3.51±0.58, 4.07±2.76 and 5.54±3.38 years, respectively. The mean LogMAR BCVA (±SD) at baseline in TLOF, TM and MLOF groups was 0.89±0.25, 0.67±0.38 and 0.81±0.35 for right, and 0.88±0.26, 0.69±0.33 and 0.78±0.33 for left eyes, respectively. The difference in BCVA between groups at baseline was significant in right (p=0.03) and left eyes (p=0.035). Mean outer nuclear layer thickness (±SD) at baseline in TLOF, MLOF and TM groups was 37.07±15.20 µm, 40.67±12.53 and 40.38±18.67, respectively, which was not significantly different (p=0.85). The mean ellipsoid zone width (EZW) loss (±SD) was 2051 µm (±1318) for patients in the TLOF, and 1314 µm (±965) for MLOF. Only one patient in the TM group had EZW loss at presentation. There was considerable overlap in ERG findings, although the largest DA 10 ERG b-waves were associated with TLOF and the smallest with TM variants. Conclusions Patients with missense alterations had better BCVA and greater structural integrity. This is important for patient prognostication and counselling, as well as stratification for future gene therapy trials.
AB - Background/aims To investigate genotype-phenotype associations in patients with KCNV2 retinopathy. Methods Review of clinical notes, best-corrected visual acuity (BCVA), molecular variants, electroretinography (ERG) and retinal imaging. Subjects were grouped according to the combination of KCNV2 variants-two loss-of-function (TLOF), two missense (TM) or one of each (MLOF)-and parameters were compared. Results Ninety-two patients were included. The mean age of onset (mean±SD) in TLOF (n=55), TM (n=23) and MLOF (n=14) groups was 3.51±0.58, 4.07±2.76 and 5.54±3.38 years, respectively. The mean LogMAR BCVA (±SD) at baseline in TLOF, TM and MLOF groups was 0.89±0.25, 0.67±0.38 and 0.81±0.35 for right, and 0.88±0.26, 0.69±0.33 and 0.78±0.33 for left eyes, respectively. The difference in BCVA between groups at baseline was significant in right (p=0.03) and left eyes (p=0.035). Mean outer nuclear layer thickness (±SD) at baseline in TLOF, MLOF and TM groups was 37.07±15.20 µm, 40.67±12.53 and 40.38±18.67, respectively, which was not significantly different (p=0.85). The mean ellipsoid zone width (EZW) loss (±SD) was 2051 µm (±1318) for patients in the TLOF, and 1314 µm (±965) for MLOF. Only one patient in the TM group had EZW loss at presentation. There was considerable overlap in ERG findings, although the largest DA 10 ERG b-waves were associated with TLOF and the smallest with TM variants. Conclusions Patients with missense alterations had better BCVA and greater structural integrity. This is important for patient prognostication and counselling, as well as stratification for future gene therapy trials.
KW - Dystrophy
KW - Electrophysiology
KW - Genetics
KW - Imaging
KW - Retina
UR - https://www.scopus.com/pages/publications/85199713622
U2 - 10.1136/BJO-2023-323640
DO - 10.1136/BJO-2023-323640
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 37852740
AN - SCOPUS:85199713622
SN - 0007-1161
VL - 108
SP - 1137
EP - 1144
JO - British Journal of Ophthalmology
JF - British Journal of Ophthalmology
IS - 8
ER -